Literature DB >> 9149701

Orally active prostacyclin analogue in primary pulmonary hypertension.

Y Okano, T Yoshioka, A Shimouchi, T Satoh, T Kunieda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9149701     DOI： 10.1016/S0140-6736(97)24019-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.

Authors:  Ezequiel Balmori Melian; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Vascular effects of prostacyclin: does activation of PPARδ play a role?

Authors:  Zvonimir S Katusic; Anantha V Santhanam; Tongrong He
Journal:  Trends Pharmacol Sci       Date:  2012-06-23       Impact factor: 14.819

3.  [Cardiovascular monitoring of patients with systemic lupus erythematosus].

Authors:  H Schotte; H Becker; W Domschke; M Gaubitz
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

Review 4.  New therapies for chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

5.  Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension.

Authors:  N Nagaya; Y Shimizu; T Satoh; H Oya; M Uematsu; S Kyotani; F Sakamaki; N Sato; N Nakanishi; K Miyatake
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

6.  Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue.

Authors:  C D Vizza; S Sciomer; S Morelli; C Lavalle; P Di Marzio; D Padovani; R Badagliacca; A R Vestri; R Naeije; F Fedele
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

7.  Beraprost sodium attenuates cigarette smoke extract-induced apoptosis in vascular endothelial cells.

Authors:  Yan Chen; Hong Luo; Naixin Kang; Chaxiang Guan; Yingjiao Long; Jun Cao; Qin Shen; Junli Li; Min Yang; Hong Peng; Ping Chen
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

Review 8.  Drug treatment of pulmonary arterial hypertension: current and future agents.

Authors:  Marius M Hoeper
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 9.  Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.

Authors:  Satyan Lakshminrusimha; Bobby Mathew; Corinne L Leach
Journal:  Semin Perinatol       Date:  2016-01-14       Impact factor: 3.300

Review 10.  What Is the Role of Oral Prostacyclin Pathway Medications in Pulmonary Arterial Hypertension Management?

Authors:  Rama El Yafawi; Joel A Wirth
Journal:  Curr Hypertens Rep       Date:  2017-10-25       Impact factor: 5.369
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.